Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ko Sasaki

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 29, 2009
[Molecular pathogenesis of chronic myeloid leukemia]Ko Sasaki, Kinuko Mitani
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 28, 2010
[Hematological disorder]Ko Sasaki, Kinuko Mitani
International Journal of Hematology|May 26, 2009
Presentation of familial Mediterranean fever in a heterozygous MEFV mutation triggered by immunosuppressive therapy for myelodysplastic syndromeKo Sasaki, Toshiyuki Tahara, Kinuko Mitani
Cancer Science|February 15, 2008
Histone deacetylase inhibitors trichostatin A and valproic acid circumvent apoptosis in human leukemic cells expressing the RUNX1 chimeraKo Sasaki, Tetsuya Yamagata, Kinuko Mitani
Journal of Magnetic Resonance Imaging : JMRI|May 1, 2010
Optimal fast T2-weighted magnetic resonance microscopy imaging of the eye and its clinical applicationKeizo Tanitame, Ko Sasaki, Takashi Sone, et al.
Cancer Science|June 17, 2005
TEL/ETV6 accelerates erythroid differentiation and inhibits megakaryocytic maturation in a human leukemia cell line UT-7/GMWataru Takahashi, Ko Sasaki, Norio Kvomatsu, et al.
Radiological Physics and Technology|April 10, 2026
Uncertainty-aware deep learning for classifying colonic fdg-pet uptake using radiomic featuresKazuhiro Ishida, Ko Sasaki, Kaoru Ono, et al.
International Journal of Hematology|June 5, 2012
Acute myeloid leukemia with t(7;21)(q11.2;q22) expresses a novel, reversed-sequence RUNX1-DTX2 chimeraKazuhiro Maki, Ko Sasaki, Fusako Sugita, et al.
International Journal of Hematology|December 20, 2012
Fadd and Skp2 are possible downstream targets of RUNX1-EVI1Kazuhiro Maki, Fusako Sugita, Yuka Nakamura, et al.
Leukemia & Lymphoma|April 4, 2013
Overexpression of MIR9 indicates poor prognosis in acute lymphoblastic leukemiaFusako Sugita, Kazuhiro Maki, Yuka Nakamura, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 29, 2009
[Molecular pathogenesis of chronic myeloid leukemia]Ko Sasaki, Kinuko Mitani
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 28, 2010
[Hematological disorder]Ko Sasaki, Kinuko Mitani
International Journal of Hematology|May 26, 2009
Presentation of familial Mediterranean fever in a heterozygous MEFV mutation triggered by immunosuppressive therapy for myelodysplastic syndromeKo Sasaki, Toshiyuki Tahara, Kinuko Mitani
Cancer Science|February 15, 2008
Histone deacetylase inhibitors trichostatin A and valproic acid circumvent apoptosis in human leukemic cells expressing the RUNX1 chimeraKo Sasaki, Tetsuya Yamagata, Kinuko Mitani
Journal of Magnetic Resonance Imaging : JMRI|May 1, 2010
Optimal fast T2-weighted magnetic resonance microscopy imaging of the eye and its clinical applicationKeizo Tanitame, Ko Sasaki, Takashi Sone, et al.
Cancer Science|June 17, 2005
TEL/ETV6 accelerates erythroid differentiation and inhibits megakaryocytic maturation in a human leukemia cell line UT-7/GMWataru Takahashi, Ko Sasaki, Norio Kvomatsu, et al.
Radiological Physics and Technology|April 10, 2026
Uncertainty-aware deep learning for classifying colonic fdg-pet uptake using radiomic featuresKazuhiro Ishida, Ko Sasaki, Kaoru Ono, et al.
International Journal of Hematology|June 5, 2012
Acute myeloid leukemia with t(7;21)(q11.2;q22) expresses a novel, reversed-sequence RUNX1-DTX2 chimeraKazuhiro Maki, Ko Sasaki, Fusako Sugita, et al.
International Journal of Hematology|December 20, 2012
Fadd and Skp2 are possible downstream targets of RUNX1-EVI1Kazuhiro Maki, Fusako Sugita, Yuka Nakamura, et al.
Leukemia & Lymphoma|April 4, 2013
Overexpression of MIR9 indicates poor prognosis in acute lymphoblastic leukemiaFusako Sugita, Kazuhiro Maki, Yuka Nakamura, et al.
Pageof 6